Home
News
Interviews
Companies
Videos
Markets
Subscribe
The
Latest
The Latest
News
Mydecine Innovations Group Announces Private Placement; Interim Changes to Management and Board of Directors
News
PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Disease
News
Filament Health Announces Eighth Patent Issuance
News
PharmAla Biotech First Publicly Traded Company to Produce GMP MDMA
More Articles
FEATURED
Algernon Pharmaceuticals Announces Private Placement
News
Awakn Life Sciences Signs Second Licensing Partnership Agreement and Expands Commercial Operations Into Canada
News
PharmAla Biotech First Publicly Traded Company to Produce GMP MDMA
Trending
#
News
Awakn Life Sciences Expands Commercial Operations into the U.S. - First Licensing Partnership Agreement with Revitalist
#
News
Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical Trial
#
Spotlight
Spotlight Interview | Carey Turnbull, Co-founder and CEO of B.More
#
News
MindMed Reports Second Quarter 2022 Financial Results and Business Highlights
#
News
Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial
Companies
#
ATAI Life Sciences
NEO
NASDAQ
CSE
TSXV
Private Company
Non-Profit
#
Compass Pathways
NEO
NASDAQ
CSE
TSXV
Private Company
Non-Profit
#
Mind Medicine (MindMed)
NEO
NASDAQ
CSE
TSXV
Private Company
Non-Profit
#
Cybin Inc.
NEO
NASDAQ
CSE
TSXV
Private Company
Non-Profit
#
Revive Therapeutics
NEO
NASDAQ
CSE
TSXV
Private Company
Non-Profit